# Implantation or Injectable Dosage Form New Animal Drugs; Enrofloxacin
> **Food and Drug Administration** · Final rule. · Published 2007-03-09 · Effective 2007-03-09 · 72 FR 10596
## Document
- **Document number:** E7-4206
- **Category:** other
- **Sub-agency:** Food and Drug Administration
- **Federal Register citation:** 72 FR 10596
- **CFR reference:** 21 CFR 522
- **Publication date:** 2007-03-09
- **Effective date:** 2007-03-09
## Abstract

The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect approval of a supplemental new animal drug application (NADA) filed by Bayer HealthCare LLC. The supplemental NADA provides for changing scientific nomenclature for a bovine respiratory pathogen on labeling for enrofloxacin injectable solution.

## Source
- [Federal Register document](https://www.federalregister.gov/documents/2007/03/09/E7-4206/implantation-or-injectable-dosage-form-new-animal-drugs-enrofloxacin)
---
*AI Analytics · CC0 1.0*